Equities research analysts at StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Get Free Report) in a report released on Wednesday. The firm set a “sell” rating on the stock.
Bio-Path Stock Performance
Shares of NASDAQ:BPTH opened at $0.82 on Wednesday. The stock’s fifty day simple moving average is $0.89 and its two-hundred day simple moving average is $1.07. Bio-Path has a 1-year low of $0.59 and a 1-year high of $9.99.
About Bio-Path
Want More Great Investing Ideas?
Further Reading
- Five stocks we like better than Bio-Path
- How to invest in marijuana stocks in 7 steps
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Effectively Use the MarketBeat Ratings Screener
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Read Stock Charts for Beginners
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Bio-Path Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Path and related companies with MarketBeat.com's FREE daily email newsletter.